Pharmacokinetics of the Long‐Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 3, 2016-05 ,pp. : 216-224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin aspart: a novel rapid-acting human insulin analogue

By Gammeltoft S.   Hansen B.F.   Dideriksen L.   Lindholm A.   Schäffer L.   Trüb T.   Dayan A.   Kurtzhals P.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1431-1442

Informa Healthcare

Access to resources Recommend Favorite

Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

By Maria Gabriella Matera  

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 503-515

Adis International

Access to resources Recommend Favorite

Stability of Two Long‐Acting Insulin Formulations after 28 Days

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 37-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 9, 2005-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite